US 6593493
RXR modulators with improved pharmacologic profile
expired A61PA61P17/00A61P17/02
Quick answer
US patent 6593493 (RXR modulators with improved pharmacologic profile) held by Ligand Pharmaceuticals Incorporated expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Jul 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 85
- CPC classes
- A61P, A61P17/00, A61P17/02, A61P17/04, A61P17/06